ANDREW COSENZA: Open Payments
NPI 1356116057 · STRATFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,698 in 104 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $406 · 2025 $10,698
Speaker / faculty: $6,900Food & beverage: $2,678Travel & lodging: $1,120
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 31 | $8,915 |
| ABBVIE INC. | 17 | $354 |
| Gilead Sciences, Inc. | 12 | $264 |
| Lilly USA, LLC | 8 | $236 |
| Indivior Inc. | 7 | $196 |
| Novo Nordisk Inc | 5 | $111 |
| Antares Pharma, Inc. | 4 | $89 |
| Axsome Therapeutics, Inc. | 1 | $89 |
| Amgen Inc. | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $56 |
Products named: APRETUDE, SUBLOCADE, VRAYLAR, Yeztugo, UBRELVY, ZEPBOUND, MOUNJARO, XYOSTED.
Industry payments across CT — which companies pay providers there.
